LGALS7 and colorectal carcinoma: In this study, we found that ncRNA PANC754 can downregulate the level of LGALS7 on the CRC cell surface, so we tried to combine the overexpression of PANC754 with Monalizumab in a CRC and PBMCs co-culture system, in order to evaluate whether PANC754 increases the effect of Monalizumab.